Genomes and Genes
Alias: "Bacillus marcescens" (Bizio 1823) Trevisan in de Toni and Trevisan 1889, Bacillus marcescens, Serratia marcescens Bizio 1823, Pantoea sp. NAB7
Publications262 found, 100 shown here
- [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria]Jun Igari
Department of Clinical Pathology, Juntendo University, School of Medicine
Jpn J Antibiot 55:22-60. 2002..n = 192), Klebsiella oxytoca (n = 157), Enterobacter cloacae (n = 189), Enterobacter aerogenes (n = 93), Serratia marcescens (n = 172), Serratia liquefaciens (n = 24), Citrobacter freundii (n = 177), Citrobacter koseri (n = 70), ..
- Antimicrobial susceptibility of respiratory isolates of Enterobacteriaceae and Staphylococcus aureus in Italy: incidence and trends over the period 1997-1999R Fontana
Department of Pathology, University of Verona, Italy
Eur J Clin Microbiol Infect Dis 20:854-63. 2001..n=870), Escherichia coli (n=684), Enterobacter cloacae (n=342), Enterobacter aerogenes (n=187) and Serratia marcescens (n=135) as well as the MICs of 11 antibiotics against isolates of Staphylococcus aureus (n=1,606)...
- Analysis of polar lipids from some representative enterobacteria, Plesiomonas and Acinetobacter by fast atom bombardment-mass spectrometryH S Aluyi
Department of Cell and Structural Biology, University of Manchester Dental School, UK
J Appl Bacteriol 73:426-32. 1992..Morganella morganii, Plesiomonas shigelloides, Proteus mirabilis (3 strains), Serratia liquefaciens and Serratia marcescens. Negative-ion spectra provide data for twenty-seven major carboxylate anions (m/z 209-325) and for thirty-..
- Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescensK S Thomson
Center for Research in Anti Infectives and Biotechnology, Creighton University School of Medicine, Omaha, Nebraska 68178, USA
Antimicrob Agents Chemother 43:1393-400. 1999..pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens possessing well-characterized beta-lactamases...
- Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesiiI Stock
Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, D 53115 Bonn, Germany
Int J Antimicrob Agents 22:35-47. 2003The natural susceptibility of 77 strains of Serratia marcescens and 41 strains of the S. liquefaciens complex (S. liquefaciens sensu stricto (n=21), S. grimesii (n=10), S...
- Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in TaiwanPo Ren Hsueh
Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, 7, Chung Shan South Road, Taipei, Taiwan
Int J Antimicrob Agents 26:463-72. 2005..Disk susceptibility data of Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Serratia marcescens, Proteus spp., Pseudomonas aeruginosa, Acinetobacter spp...
- [Studies on respiratory infections in primary care clinic (IV). Antibiotic sensitivity of bacteria isolated from patients with respiratory infections visiting 21 private clinics in the Tohoku District of Japan]A Watanabe
Department of Internal Medicine, Tohoku University
Kansenshogaku Zasshi 64:1220-31. 1990..of Escherichia coli, 66 strains of Klebsiella pneumoniae, 26 strains of Enterobacter cloacae, 20 strains of Serratia marcescens, 12 strains of Pseudomonas aeruginosa and 42 strains of Acinetobacter calcoaceticus, isolated from the ..
- The in-vitro antimicrobial activity of some medicinal plants against beta-lactam-resistant bacteriaJoseph Gangoue-Pieboji
Centre for Research on Medicinal Plants and Traditional Medicine, Institute of Medical Research and Medicinal Plant Studies, Yaounde, Cameroon
J Infect Dev Ctries 3:671-80. 2009..In effort to identify novel bacterial agents, this study was initiated to evaluate the antimicrobial properties of 17 crude extracts from 12 medicinal plants against beta-lactam-resistant bacteria...
- Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from KoreaYeon Joon Park
Department of Clinical Pathology, College of Medicine, The Catholic University of Korea, Kangnam St Mary s Hospital, 505 Banpo Dong, Seocho Ku, Seoul 137 701, Korea
J Antimicrob Chemother 60:868-71. 2007..To investigate the prevalence of qnr determinants, their influence on quinolone susceptibility and their association with other plasmid-mediated genes in AmpC-producing Enterobacteriaceae without any selection criteria...
- [Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test]T Uete
Department of Clinical Investigation, Kitano Hospital
Jpn J Antibiot 40:1906-16. 1987..56 micrograms/ml. LMOX was less active against Serratia marcescens, inhibiting about 43% of strains at a level of 6.25 micrograms/ml...
- Nucleotide sequence of the Serratia marcescens threonine operon and analysis of the threonine operon mutations which alter feedback inhibition of both aspartokinase I and homoserine dehydrogenase IK Omori
Research Laboratory of Applied Biochemistry, Tanabe Seiyaku Co, Ltd, Osaka, Japan
J Bacteriol 175:785-94. 1993The nucleotide sequence of the Serratia marcescens threonine operon (thrA1A2BC) was determined...
- Serratia type pore forming toxinsR Hertle
Laboratory of Molecular Biology, Bethesda, MD, USA
Curr Protein Pept Sci 1:75-89. 2000The Serratia marcescens hemolysin represents a new type of hemolysin and has been studied in great molecular detail with regard to structure, activation and secretion. It has nothing in common with the pore forming toxins of E...
- Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centersCorinne Arpin
Laboratoire de Microbiologie, Universite de Bordeaux 2, 33076 Bordeaux Cedex, France
Antimicrob Agents Chemother 47:3506-14. 2003..pneumoniae isolates; 6 Escherichia coli isolates; 3 Proteus mirabilis isolates; and 1 isolate each of Serratia marcescens, Morganella morganii, and Providencia stuartii...
- Evaluation of Phoenix Automated Microbiology System for detecting extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescensYeon Joon Park
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Kangnam St Mary s Hospital, 505 Banpo Dong, Seocho Ku, Seoul 137 701, Korea
Ann Clin Lab Sci 37:75-8. 2007..among chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens. The study was conducted on 72 non-repetitive ESBL producers (33 E. cloacae, 13 E. aerogenes, 14 C...
- Serratia marcescens infection associated with early abortion in cows and buffaloesA M Das
Department of Bacteriology, Bombay Veterinary College, Parel, India
Epidemiol Infect 101:143-9. 1988b>Serratia marcescens was isolated in pure culture from cases of septic abortion in 4 cows on one farm and 10 buffaloes on two other farms...
- Spontaneous bacterial peritonitis causing Serratia marcescens and Proteus mirabilis ventriculoperitoneal shunt infection. Case reportLuis M Tumialan
Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA
J Neurosurg 105:320-4. 2006..Cerebrospinal fluid (CSF) cultures grew Serratia marcescens and Proteus mirabilis...
- Production, characterization, cloning and sequence analysis of a monofunctional catalase from Serratia marcescens SYBC08Hua Wei Zeng
The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, Jiangsu, China
J Basic Microbiol 51:205-14. 2011A monofunctional catalase from Serratia marcescens SYBC08 produced by liquid state fermentation in 7 liter fermenter was isolated and purified by ammonium sulfate precipitation (ASP), ion exchange chromatography (IEC), and gel filtration ..
- Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology wardL C Hibbert-Rogers
Department of Microbiology, University of Leeds, UK
J Antimicrob Chemother 36:65-82. 1995..and 1 Serratia marcescens. Clinical isolates were resistant to penicillins and to ceftazidime...
- Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratorySoo Young Kim
Center for Research in Anti Infectives and Biotechnology, Department of Medical Microbiology and Immunology, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA
J Clin Microbiol 45:2798-801. 2007..Sixteen isolates (4 Acinetobacter baumannii isolates, 6 Pseudomonas aeruginosa isolates, 1 Serratia marcescens isolate, 1 Aeromonas hydrophila isolate, 1 Aeromonas veronii isolate, 2 Chryseobacterium meningosepticum ..
- Isolation and sequence analysis of rpoH genes encoding sigma 32 homologs from gram negative bacteria: conserved mRNA and protein segments for heat shock regulationK Nakahigashi
HSP Research Institute, Kyoto Research Park, Japan
Nucleic Acids Res 23:4383-90. 1995..sequenced from five gram negative proteobacteria (gamma or alpha subgroup): Enterobacter cloacae (gamma), Serratia marcescens (gamma), Proteus mirabilis (gamma), Agrobacterium tumefaciens (alpha) and Zymomonas mobilis (alpha)...
- A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in BrazilR Bonnet
Laboratoire de Bacteriologie, Faculte de Medecine, 63001 Clermont Ferrand cedex, France
Antimicrob Agents Chemother 44:3061-8. 2000b>Serratia marcescens Rio-5, one of 18 extended-spectrum beta-lactamase (ESBL)-producing strains isolated in several hospitals in Rio de Janeiro (Brazil) in 1996 and 1997, exhibited a high level of resistance to aztreonam (MIC, 512 ..
- Eggshell factors influencing eggshell penetration and whole egg contamination by different bacteria, including Salmonella enteritidisK De Reu
Department of Animal Product Quality and Transformation Technology, Agricultural Research Centre Ghent, Ministry of the Flemish Community, Brusselsesteenweg 370, 9090 Melle, Belgium
Int J Food Microbiol 112:253-60. 2006..b>Serratia marcescens, Carnobacterium sp., Pseudomonas sp. and Salmonella enteritidis, recovered from egg contents, were studied...
- In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibioticsJ W Gu
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032
Antimicrob Agents Chemother 34:189-95. 1990..It inhibited the majority of members of the family Enterobacteriaceae, except for some Serratia marcescens, Citrobacter freundii, and Enterobacter cloacae strains, at less than or equal to 0...
- Evaluation of a new generation of plastic culture bottles with an automated microbial detection system for nine common contaminating organisms found in PLT componentsM E Brecher
Transfusion Medicine Service, CB 7600, University of North Carolina Hospitals, 101 Manning Drive, Chapel Hill, NC 27514, USA
Transfusion 44:359-63. 2004..The recovery of nine organisms seeded into PLTs with new plastic culture bottles was studied in comparison to the current glass bottles. The use of plastic instead of glass would be expected to reduce the risk of injury...
- Temporal association of entomopathogenic nematodes (Rhabditida: Steinernematidae and Heterorhabditidae) and bacteriaDawn H Gouge
University of Arizona, MAC, 37860 West Smith Enke Road, Phoenix, AZ 85239, USA
J Invertebr Pathol 91:147-57. 2006..Pseudomonas fluorescens type C, Serratia marcescens, Citrobacter freundii, and Serratia proteomaculans...
- Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organismsM E Brecher
University of North Carolina Hospitals, Chapel Hill, North Carolina 27514, USA
Transfusion 41:477-82. 2001..Approximately 1 in 2000 platelet components are bacterially contaminated. The time to detection of 15 seeded organisms in platelets recovered from an automated culture system was studied...
- A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacyRebecca H Sunenshine
Centers for Disease Control and Prevention, Arizona Dept of Health Services, 150 N 18th Ave, Ste 150, Phoenix, AZ 85007, USA
Clin Infect Dis 45:527-33. 2007..In 2005, the Centers for Disease Control and Prevention received reports of cases of Serratia marcescens bloodstream infection occurring in patients who underwent cardiac surgical procedures in Los Angeles, ..
- Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospitalJia Chang Cai
2nd Affiliated Hospital of Zhejiang University, 88 Jiefang Rd, Hangzhou, China 310009
Antimicrob Agents Chemother 52:2014-8. 2008Twenty-one Serratia marcescens, ten Klebsiella pneumoniae, and one Escherichia coli isolate with carbapenem resistance or reduced carbapenem susceptibility were recovered from intensive care units (ICUs) in our hospital...
- Purification and partial characterization of psychrotrophic Serratia marcescens lipaseAdham M Abdou
Department of Food Hygiene, Faculty of Veterinary Medicine, Benha University, Moshtohor 13736 Kaliobyia, Egypt
J Dairy Sci 86:127-32. 2003b>Serratia marcescens isolated from raw milk was found to produce extracellular lipase. The growth of this organism could contribute to flavor defects in milk and dairy products...
- Utilization of mucus from the coral Acropora palmata by the pathogen Serratia marcescens and by environmental and coral commensal bacteriaCory J Krediet
University of Florida, Gainesville, 32611, USA
Appl Environ Microbiol 75:3851-8. 2009..commensal bacteria ("Photobacterium mandapamensis" and Halomonas meridiana) and by opportunistic Serratia marcescens pathogens. S...
- Pathogenic capacity of proteases from Serratia marcescens and Pseudomonas aeruginosa and their suppression by chicken egg white ovomacroglobulinA Molla
Department of Microbiology, Kumamoto University Medical School, Japan
Infect Immun 55:2509-17. 1987The pathogenicities of three proteases from Serratia marcescens, two proteases from Pseudomonas aeruginosa, and one thermolysin from Bacillus stearothermophilus were examined...
- Characterization of an exochitinase from Epiphyas postvittana nucleopolyhedrovirus (family Baculoviridae)Vivienne L Young
Department of Microbiology and Immunology, School of Medical Sciences, University of Otago, PO Box 56, Dunedin, New Zealand
J Gen Virol 86:3253-61. 2005..Homology modelling of the chitinase of Epiphyas postvittana nucleopolyhedrovirus (EppoNPV) against Serratia marcescens chitinase A indicated that the enzyme possesses an N-terminal polycystic kidney 1 (PKD1) domain for chitin-..
- Kinetic analysis of growth rate, ATP, and pigmentation suggests an energy-spilling function for the pigment prodigiosin of Serratia marcescensPryce L Haddix
Department of Biology, Auburn University Montgomery, P O Box 244023, Montgomery, AL 36124 4023, USA
J Bacteriol 190:7453-63. 2008b>Serratia marcescens is a gram-negative environmental bacterium and opportunistic pathogen. S. marcescens expresses prodigiosin, a bright red and cell-associated pigment which has no known biological function for producing cells...
- Infectious crystalline keratopathy caused by Serratia marcescensChing Long Chen
Department of Ophthalmology, Tri Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
Cornea 26:1011-3. 2007..To report the case of a 70-year-old woman with Serratia infectious crystalline keratopathy...
- [Isolation and characterization of Serratia marcescens phage]Long Yu
State Research Center for Bio protective Equipment and Engineering Technology, State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China
Wei Sheng Wu Xue Bao 48:498-502. 2008To isolate the bacteriophage of Serratia marcescens (8039) from sewage, and to study on its biological characteristics.
- In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituentJ Guinea
Department of Sanitary Microbiology and Parasitology, Faculty of Pharmacy, University of Barcelona, Spain
Antimicrob Agents Chemother 37:868-74. 1993..03 and 1 microgram/ml were observed, with the exception of those against Serratia marcescens and Providencia spp., and a MIC90 of 2 micrograms/ml against Pseudomonas aeruginosa was obtained...
- Ceftazidime combined with mecillinam: serum bactericidal titres compared with in-vitro synergy against gram-negative bacilliP Van der Auwera
Service de Medecine, Institut Jules Bordet, Universite Libre de Bruxelles, Belgium
J Antimicrob Chemother 21:745-53. 1988..Ten strains each of Klebsiella pneumoniae, Serratia marcescens, Citrobacter freundii, Salmonella spp. and Yersinia spp. and nine strains each of Acinetobacter spp...
- Activity domains of the TonB proteinI Traub
Mikrobiologie II, Universitat Tubingen, Germany
Mol Microbiol 8:409-23. 1993..Differences in the activities of the Escherichia coli and the Serratia marcescens TonB proteins were used to identify TonB functional domains. In E...
- Production, purification and characterization of a 50-kDa extracellular metalloprotease from Serratia marcescensP R Salamone
Department of Molecular Biology and Microbiology, University of Central Florida, Orlando 32816 2360, USA
Appl Microbiol Biotechnol 48:317-24. 1997The extracellular metalloprotease (SMP 6.1) produced by a soil isolate of Serratia marcescens NRRL B-23112 was purified and characterized. SMP 6...
- A novel medium for the enhanced cell growth and production of prodigiosin from Serratia marcescens isolated from soilAnuradha V Giri
Centre for Biotechnology, Anna University, Chennai 600025, India
BMC Microbiol 4:11. 2004Prodigiosin produced by Serratia marcescens is a promising drug owing to its reported characteristics of having antifungal, immunosuppressive and antiproliferative activity...
- Illness-induced anorexia and its possible function in the caterpillar, Manduca sextaShelley A Adamo
Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada
Brain Behav Immun 21:292-300. 2007..Injecting Manduca sexta larvae (caterpillars) with live bacteria (Serratia marcescens), heat-killed bacteria or bacterial lipopolysaccharides resulted in a decline in feeding, demonstrating ..
- (123)I-Labeled chitinase as specific radioligand for in vivo detection of fungal infections in miceRien Siaens
Laboratory of Radiopharmacy, Gent University, Gent, Belgium
J Nucl Med 45:1209-16. 2004..ChiB_E144Q (ChiB = chitinase B) from Serratia marcescens was labeled with (123)I, and in vitro and in vivo studies were assessed.
- Characterization of the mineral phosphate solubilizing activity of Serratia marcescens CTM 50650 isolated from the phosphate mine of GafsaMounira Ben Farhat
Laboratoire d Enzymes et de Metabolites des Procaryotes LEMP, Centre de Biotechnologie de Sfax, Route de Sidi Mansour Km 6, BP 1177, 3018 Sfax, Tunisia
Arch Microbiol 191:815-24. 2009The mineral phosphate solubilizing (MPS) ability of a Serratia marcescens strain, namely CTM 50650, isolated from the phosphate mine of Gafsa, was characterized on a chemically defined medium (NBRIP broth)...
- Validation of BacT/ALERT plastic culture bottles for use in testing of whole-blood-derived leukoreduced platelet-rich-plasma-derived plateletsM E Brecher
University of North Carolina, Chapel Hill, North Carolina 27514, USA
Transfusion 44:1174-8. 2004..This study validated the BacT/ALERT for use in testing pooled PRP-derived PLTs with nine contaminating organisms...
- Prevalence and characteristics of aac(6')-Ib-cr in AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens: a multicenter study from KoreaSoo Young Kim
Department of Laboratory Medicine, The Catholic University of Korea, St Vincent s Hospital, Paldal Gu, Suwon, South Korea
Diagn Microbiol Infect Dis 63:314-8. 2009..A total of 479 clinical isolates of Enterobacter cloacae (179), Citrobacter freundii (134), and Serratia marcescens (166) from 12 laboratories between March and July 2005 were examined...
- Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteriaYeon Joon Park
Department of Clinical Pathology, College of Medicine, The Catholic University of Korea, Kangnam St Mary s Hospital, Seoul 137 040, Korea
Diagn Microbiol Infect Dis 51:265-9. 2005..beta-lactamases (ESBLs) among AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens. The 413 isolates (158 E. cloacae, 126 C. freundii, and 129 S...
- Re-evaluation of the serotypes of Serratia marcescens and separation into two schemes based on lipopolysaccharide (O) and capsular polysaccharide (K) antigensH M Aucken
Laboratory of Hospital Infection, Central Public Health Laboratory, London, UK
Microbiology 144:639-53. 1998Chemical and serological analysis has revealed that many of the 29 O serotype reference strains of Serratia marcescens contain both neutral and acidic polysaccharides which correspond to LPS O antigens and capsular K antigens, ..
- Case-control analysis of endemic Serratia marcescens bacteremia in a neonatal intensive care unitMatthew J Bizzarro
Divisions of Perinatal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8064, USA
Arch Dis Child Fetal Neonatal Ed 92:F120-6. 2007b>Serratia marcescens is an opportunistic gram-negative rod which typically infects compromised hosts.
- Novel tetracycline resistance determinant isolated from an environmental strain of Serratia marcescensStuart A Thompson
Department of Biochemistry and Molecular Biology, Medical College of Georgia, 1120 15th Street, Augusta, GA 30912 2100, USA
Appl Environ Microbiol 73:2199-206. 2007Resistances to tetracycline and mercury were identified in an environmental strain of Serratia marcescens isolated from a stream highly contaminated with heavy metals...
- The importance of chitobiase and N-acetylglucosamine (GlcNAc) uptake in N,N'-diacetylchitobiose [(GlcNAc)2] utilization by Serratia marcescens 2,170Tadayuki Toratani
Department of Applied Biological Chemistry, Faculty of Agriculture, Niigata University, 8050 Ikarashi 2, Niigata 950 2181, Japan
Microbiology 154:1326-32. 2008..GlcNAc)(2)] is the main degradation product from chitin by the action of chitinases of Serratia marcescens 2170...
- Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringesDavid Blossom
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Arch Intern Med 169:1705-11. 2009To investigate clusters of Serratia marcescens (SM) bloodstream infections (BSIs) at health care facilities in several states and determine whether contaminated prefilled heparin and isotonic sodium chloride solution (hereinafter, saline)..
- Serratia marcescens internalization and replication in human bladder epithelial cellsRalf Hertle
Microbiology Membranphysiology, University of Tubingen, Germany
BMC Infect Dis 4:16. 2004b>Serratia marcescens, a frequent agent of catheterization-associated bacteriuria, strongly adheres to human bladder epithelial cells in culture...
- Outbreak of Serratia marcescens infections following injection of betamethasone compounded at a community pharmacyRachel Civen
Los Angles County Department of Health Services, Acute Communicable Disease Control Program, Los Angeles, CA 90012, USA
Clin Infect Dis 43:831-7. 2006In June 2001, following the report of 4 patients with Serratia marcescens meningitis who received epidural injections of betamethasone compounded at a community pharmacy, we initiated an outbreak investigation.
- Effects of temperature, nutrients, organic matter and coral mucus on the survival of the coral pathogen, Serratia marcescens PDL100Erin E Looney
Department of Environmental Health Science, The University of Georgia, Athens, GA, USA
Environ Microbiol 12:2479-85. 2010b>Serratia marcescens is an enteric bacterium that causes white pox disease in elkhorn coral, Acropora palmata; however, it remains unclear if the pathogenic strain has adapted to seawater or if it requires a host or reservoir for survival...
- Effect of chemical and physical parameters on the production of L-asparaginase from a newly isolated Serratia marcescens SK-07A Agarwal
Biochemical Engineering Laboratory, Department of Biotechnology, Indian Institute of Technology Guwahati, Guwahati, Assam, India
Lett Appl Microbiol 52:307-13. 2011..of carbon and nitrogen sources of the medium in shake flask experiments and evaluate the effect of pH and dissolved oxygen (DO) on the production of L-asparaginase from a newly isolated Serratia marcescens SK-07 in a batch bioreactor.
- Morphological and genetic analysis of three bacteriophages of Serratia marcescens isolated from environmental waterKenshi Matsushita
Department of Pediatrics, Kochi Medical School, Nankoku, Kochi, Japan
FEMS Microbiol Lett 291:201-8. 2009Increases in multidrug-resistant strains of Serratia marcescens are of great concern in pediatrics, especially in neonatal intensive care units...
- SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strainsA M Queenan
The R W Johnson Pharmaceutical Research Institute, Raritan, New Jersey 08869, USA
Antimicrob Agents Chemother 44:3035-9. 2000Three sets of carbapenem-resistant Serratia marcescens isolates have been identified in the United States: 1 isolate in Minnesota in 1985 (before approval of carbapenems for clinical use), 5 isolates in Los Angeles (University of ..
- Presence of a group II intron in a multiresistant Serratia marcescens strain that harbors three integrons and a novel gene fusionDaniela Centron
Departement de Biochimie et de Microbiologie, Faculte des sciences et de genie, Universite Laval, Sainte Foy, Quebec, Canada G1K 7P4
Antimicrob Agents Chemother 46:1402-9. 2002..of integrons in the dissemination of antibiotic resistance in a recent multiresistant clinical isolate, Serratia marcescens SCH88050909 (SCH909). This isolate harbors three integrons, all on a 60-kb conjugative plasmid...
- Serratia marcescens endophthalmitis associated with intravitreal injections of bevacizumabS H Lee
Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea
Eye (Lond) 24:226-32. 2010To report two cases of Serratia marcescens endophthalmitis related to presumed aliquot drug contamination, and to determine the incidence of acute endophthalmitis after intravitreal injection of bevacizumab.
- The molecular evolution of bacterial alkaline phosphatase: correlating variation among enteric bacteria to experimental manipulations of the proteinR F DuBose
Department of Genetics, Washington University School of Medicine
Mol Biol Evol 7:547-77. 1990..The nucleotide and protein sequences from the E. fergusonii and Serratia marcescens genes are presented...
- Chorismate aminations: partial purification of Escherichia coli PABA synthase and mechanistic comparison with anthranilate synthaseC T Walsh
Department of Chemistry, Massachusetts Institute of Technology, Cambridge 02139
Biochemistry 26:4734-45. 1987..Of these compounds, cycloheptadienyl analogue 11 has been found to be the most potent inhibitor of Serratia marcescens anthranilate synthase (Ki = 30 microM for an RS mixture) and of the E...
- Energy-coupled colicin transport through the outer membrane of Escherichia coli K-12: mutated TonB proteins alter receptor activities and colicin uptakeI Traub
Universitat Tubingen, FRG
FEMS Microbiol Lett 119:65-70. 1994..coli expressing TonB of Serratia marcescens, or TonB of E. coli carrying a C-terminal fragment of the S...
- Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs diseaseI Tews
European Molecular Biology Laboratory, Hamburg, Germany
Nat Struct Biol 3:638-48. 1996..The structure of Serratia marcescens chitobiase has been refined at 1.9 A resolution...
- Cyanobacteria--a potential source of new biologically active substancesS Kreitlow
Department of Pharmaceutical Biology, Ernst Moritz Arndt University Greifswald, Germany
J Biotechnol 70:61-3. 1999..effects were found against the three Gram-negative bacteria Escherichia coli, Proteus mirabilis and Serratia marcescens and the yeast Candida maltosa...
- Characterization of Pseudomonas aeruginosa chitinase, a gradually secreted proteinJ Folders
Department of Molecular Microbiology, Institute of Biomembranes, Utrecht University, Utrecht, The Netherlands
J Bacteriol 183:7044-52. 2001..The protein shows sequence similarity to the secreted chitinases ChiC of Serratia marcescens, ChiA of Vibrio harveyi, and ChiD of Bacillus circulans and consists of an activity domain and a chitin-..
- Comparsion of selected growth media for culturing Serratia marcescens, Aeromonas sp., and Pseudomonas aeruginosa as pathogens of adult Stomoxys calcitrans (Diptera: Muscidae)T J Lysyk
Research Centre, Agriculture and Agri Food Canada, Lethbridge, AB, Canada
J Med Entomol 39:89-98. 2002..were orally infected with Aeromonas sp., Pseudomonas aeruginosa (Schroeter), and Serratia marcescens Bizio that were cultured on egg-yolk media, nutrient broth, and fly egg media...
- Synthesis and antibacterial activity of dual-action agents of a beta-lactam antibiotic with cytotoxic agent mitozolomide or temozolomideYongfeng Wang
Pharmaceutical Research Institute, Aston University, Birmingham B4 7ET, UK
Eur J Med Chem 37:323-32. 2002..12a-f demonstrated some synergistic effect against bacteria. 12a, in particular, is active against ampicillin resistant (beta-lactamase-producing) strains of Serratia marcescens.
- Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000Michael A Pfaller
Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, 200 Hawikins Drive, Iowa City, IA 52242, USA
Int J Antimicrob Agents 19:383-8. 2002..904 cases), Citrobacter spp. (144) and Serratia marcescens (288)...
- Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screeningC Leopold Kurz
Centre d immunologie de Marseille Luminy, INSERM CNRS Universite de la Mediterranee, Case 906, 13288 Marseille Cedex 9, France
EMBO J 22:1451-60. 2003The human opportunistic pathogen Serratia marcescens is a bacterium with a broad host range, and represents a growing problem for public health. Serratia marcescens kills Caenorhabditis elegans after colonizing the nematode's intestine...
- The structure of the polysaccharide part of the LPS from Serratia marcescens serotype O19, including linkage region to the core and the residue at the non-reducing endEvgeny Vinogradov
Institute for Biological Sciences, National Research Council, 100 Sussex Dr, Ottawa, ON, Canada K1A 0R6
Carbohydr Res 338:2757-61. 2003The structure of the LPS from Serratia marcescens serotype O19 was investigated. Deamination of the LPS released the O-chain polysaccharide together with a fragment of the core oligosaccharide...
- Characterization of the dapA-nlpB genetic locus involved in regulation of swarming motility, cell envelope architecture, hemolysin production, and cell attachment ability in Serratia marcescensPo Chi Soo
Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, No 1 Chan Der Street, Taipei 100, Taiwan, Republic of China
Infect Immun 73:6075-84. 2005Swarming migration of Serratia marcescens requires both flagellar motility and cellular differentiation and is a population-density-dependent behavior...
- Investigation of antimicrobial activity of Pelargonium radula (Cav.) L'HéritStjepan Pepeljnjak
Department of Microbiology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
Acta Pharm 55:409-15. 2005..that the most sensitive microorganisms were Bacillus pumilus, Bacillus subtilis, Escherichia coli and Serratia marcescens. Extract prepared from fresh leaves showed significantly higher antimicrobial activity than the extract ..
- Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis modelFrancis S Mah
Charles T Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, Ophthalmology and Visual Sciences Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Cornea 26:585-8. 2007..3%), and fortified tobramycin (14 mg/mL) in the treatment of experimental Gram-negative bacterial infections of Serratia marcescens (SM) and Pseudomonas aeruginosa (PA) in the New Zealand White (NZW) rabbit keratitis model.
- Reduction of pollutants in pulp paper mill effluent treated by PCP-degrading bacterial strainsRam Chandra
Environmental Microbiology Section, Industrial Toxicology Research Centre, Post Box No 80, M G Marg, Lucknow, UP 226001, India
Environ Monit Assess 155:1-11. 2009Two PCP-degrading bacterial strains, Bacillus cereus (ITRC-S6) and Serratia marcescens (ITRC-S7) were used for the treatment of pulp and paper mill effluent at conditions; 1.0% glucose and 0...
- Spectroscopic characterization of extracellular polymeric substances from Escherichia coli and Serratia marcescens: suppression using sub-inhibitory concentrations of bismuth thiolsAppala Raju Badireddy
Department of Civil and Environmental Engineering, University of Houston, Houston, Texas 77204 4003, USA
Biomacromolecules 9:3079-89. 2008Free and bound (or capsular) EPS produced by suspended cultures of Escherichia coli and Serratia marcescens were characterized in detail using colorimetric analysis of total proteins and polysaccharides, Fourier transform infrared ..
- DNA cleavage, binding and intercalation studies of drug-based oxovanadium(IV) complexesM N Patel
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, 388 120, Gujarat, India
J Enzyme Inhib Med Chem 24:715-21. 2009..Escherichia coli, Pseudomonas aeruginosa and three Gram((+ ve)) Staphylococcus aureus, Bacillus subtilis, Serratia marcescens microorganisms using the doubling dilution technique...
- Selective detection of live bacteria combining propidium monoazide sample treatment with microarray technologyAndreas Nocker
Center for Biofilm Engineering, Montana State University, Bozeman, MT 59717, USA
J Microbiol Methods 76:253-61. 2009..The organisms comprised Pseudomonas aeruginosa, Listeria monocytogenes, Salmonella typhimurium, Serratia marcescens, and Escherichia coli O157:H7...
- Serratia nematodiphila sp. nov., associated symbiotically with the entomopathogenic nematode Heterorhabditidoides chongmingensis (Rhabditida: Rhabditidae)Chong Xing Zhang
College of Life Sciences, Nanjing Agricultural University, Nanjing, Jiangsu 210095, PR China
Int J Syst Evol Microbiol 59:1603-8. 2009..indicated that the strain is a member of the genus Serratia, sharing highest sequence similarities with Serratia marcescens subsp. sakuensis JCM 11315(T) (99.8 %), S. marcescens subsp. marcescens DSM 30121(T) (99...
- Lyngbyazothrins A-D, antimicrobial cyclic undecapeptides from the cultured Cyanobacterium lyngbya spElmi N Zainuddin
Institute of Pharmacy, Ernst Moritz Arndt University, Friedrich Ludwig Jahnstrasse 17, D 17487 Greifswald, Germany
J Nat Prod 72:1373-8. 2009..C (3) and D (4) was active against Bacillus subtilis, Escherichia coli, Pseudomonas aeruginosa, and Serratia marcescens. It seems that the acyl residue at C-5 of the Aound unit plays an important role in antimicrobial activity.
- Outbreaks of Serratia marcescens in neonatal and pediatric intensive care units: clinical aspects, risk factors and managementAlexander Voelz
Children s Hospital Medical Center, University of Bonn, Bonn, Germany
Int J Hyg Environ Health 213:79-87. 2010The following recommendations are derived from a systematic analysis of 34 Serratia marcescens outbreaks described in 27 publications from neonatal and pediatric intensive care units (NICU, PICU), in which genotyping methods were used to ..
- CTX-M and TEM as predominant types of extended spectrum beta-lactamases among Serratia marcescens isolated from solid organ recipientsA Mlynarczyk
Department of Medical Microbiology, The Medical University of Warsaw, 02 004 Warsaw, Poland
Transplant Proc 41:3253-5. 2009b>Serratia marcescens is an important pathogen in hospital infections since organisms resistant to multiple antimicrobials pose a special threat particularly among transplant patients...
- Corneal perforation with preseptal cellulitis in a patient with acute lymphocytic leukemiaSeong Kyu Im
Department of Ophthalmology and Research Institute of Medical Sciences, Chonnam National University Medical School and Hospital, Gwangju, Korea
J Korean Med Sci 25:1251-2. 2010..Microbiologic study of bloody and purulent discharge revealed Serratia marcescens. Corneal melting and perforation with iris prolapse were detected in the right eye on the 16th day...
- Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infectionM N Al-Hasan
Department of Medicine, Division of Infectious Diseases, University of Kentucky, Lexington, KY, USA
Epidemiol Infect 139:1750-6. 2011..Pseudomonas aeruginosa (OR 2·26, 95% CI 1·70-3·06), Enterobacter cloacae (OR 2·31, 95% CI 1·53-3·66), Serratia marcescens (OR 2·34, 95% CI 1·33-4·52) and Stenotrophomonas maltophilia (OR 17·94, 95% CI 3·98-314·43) were ..
- Akara Ogbomoso: microbiological examination and identification of hazards and critical control pointsA Lateef
Microbiology Unit, Department of Pure and Applied Biology, Ladoke Akintola University of Technology, PMB 4000, Ogbomoso, Nigeria
Food Sci Technol Int 16:389-400. 2010..namely; Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, Citrobacter freundii, Serratia marcescens, Proteus vulgaris, Bacillus cereus, Streptococcus pyogenes, Bacillus sp. and Shigella sp...
- Impedimetric biosensor based on self-assembled hybrid cystein-gold nanoparticles and CramoLL lectin for bacterial lipopolysaccharide recognitionMaria D L Oliveira
Departamento de Bioquimica, Universidade Federal de Pernambuco UFPE, 50670 901 Recife, PE, Brazil
J Colloid Interface Sci 362:194-201. 2011..the lectin retained its activity as observed through its interaction with LPS from Escherichia coli, Serratia marcescens, Salmonella enterica and Klebsiella pneumoniae...
- Effect of microorganisms on the plutonium oxidation statesBenedikta Luksiene
Center for Physical Sciences and Technology, Vilnius, Lithuania
Appl Radiat Isot 70:442-9. 2012..Tested bacteria Bacillus mycoides and Serratia marcescens were more effective in Pu reduction than Rhodococcus fascians...
- Antimicrobial activity of new phorbins from Jatropha curcas Linn. (Euphorbiaceae) leavesIrene M Villaseñor
Institute of Chemistry, University of the Philippines, Diliman, Quezon City, Philippines
Z Naturforsch C 66:441-6. 2011..Compound 2 was characterized as methyl pheophorbide a with 132-OH and 17- and 17(1)-CH3 moieties. It is active against Serratia marcescens.
- Biodegradation and bioremediation potential of diazinon-degrading Serratia marcescens to remove other organophosphorus pesticides from soilsMariusz Cycoń
Department of Microbiology and Virology, Medical University of Silesia, Jagiellonska 4, 41 200 Sosnowiec, Poland
J Environ Manage 117:7-16. 2013The ability of diazinon-degrading Serratia marcescens to remove organophosphorus pesticides (OPPs), i.e...
- Phosphate limitation induces the intergeneric inhibition of Pseudomonas aeruginosa by Serratia marcescens isolated from paper machinesPei An Kuo
Institute of Microbiology, University of Freiburg, Freiburg, Germany
FEMS Microbiol Ecol 84:577-87. 2013..Intergeneric inhibition of Pseudomonas aeruginosa WW5 by Serratia marcescens WW4 was identified under phosphate-limited conditions, but not in Luria-Bertani medium or M9 minimal medium...
- Designing a new chitinase with more chitin binding and antifungal activitySoheila Matroodi
National Institute of Genetic Engineering and Biotechnology, P O Box 149651 161, Tehran, Iran
World J Microbiol Biotechnol 29:1517-23. 2013..We have produced a chimeric chitinase with stronger chitin-binding capacity by fusing to Chit42 a ChBD from Serratia marcescens Chitinase B...
- The hemophore HasA from Yersinia pestis (HasAyp) coordinates hemin with a single residue, Tyr75, and with minimal conformational changeRitesh Kumar
Center for Bioinformatics, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA
Biochemistry 52:2705-7. 2013Hemophores from Serratia marcescens (HasA(sm)) and Pseudomonas aeruginosa (HasA(p)) bind hemin between two loops, which harbor the axial ligands H32 and Y75...
- Heterologous production of the lipopeptide biosurfactant serrawettin W1 in Escherichia coliStephan Thies
Institut für Molekulare Enzymtechnologie, Heinrich Heine Universität Düsseldorf and Institut für Bio und Geowissenschaften IBG 1, Forschungszentrum Julich, D 52426 Jülich, Germany
J Biotechnol 181:27-30. 2014The non-ionic biosurfactant serrawettin W1 is a lipopeptide produced by red-pigmented strains of Serratia marcescens which shows antimicrobial, antitumor and plant protecting properties...
- Phyllanthus wightianus Müll. Arg.: a potential source for natural antimicrobial agentsD Natarajan
Natural Drug Research Laboratory, Department of Biotechnology, Periyar University, Periyar Palkalai Nagar, Salem, Tamil Nadu 636 011, India
Biomed Res Int 2014:135082. 2014..Klebsiella pneumoniae, Salmonella typhimurium, Escherichia coli, Shigella flexneri, Proteus vulgaris, and Serratia marcescens) and 4 fungal pathogens (Candida albicans, Cryptococcus neoformans, Mucor racemosus, and Aspergillus niger) ..
- A direct pre-screen for marine bacteria producing compounds inhibiting quorum sensing reveals diverse planktonic bacteria that are bioactiveJamie S Linthorne
School of Pathology and Laboratory Medicine, The University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia
Mar Biotechnol (NY) 17:33-42. 2015..Of the active isolates, 21 % showed further activity against quorum-sensing-regulated pigment production by Serratia marcescens. The majority of bioactive isolates were identified by 16S ribosomal DNA (rDNA) amplification and ..
- Genome Assembly of Serratia marcescens Type Strain ATCC 13880H E Daligault
Diagnostic Systems Division DSD, United States Army Medical Research Institute of Infectious Diseases USAMRIID, Fort Detrick, Maryland, USA
Genome Announc 2:. 2014b>Serratia marcescens ATCC 13880 is the type strain of the species and a commonly used quality control strain. Here, we present the annotated genome assembly of 5.13 Mbp (59.8% G+C content) as submitted to NCBI under accession no...
- Antimicrobial activity of prodigiosin isolated from Serratia marcescens UFPEDA 398J C Lapenda
Federal University of Pernambuco, Recife, PE, CEP 50670 901, Brazil
World J Microbiol Biotechnol 31:399-406. 2015Prodigiosin is an alkaloid and natural red pigment produced by Serratia marcescens. Prodigiosin has antimicrobial, antimalarial and antitumor properties and induces apoptosis in T and B lymphocytes...
- New plasmid-mediated aminoglycoside 6'-N-acetyltransferase, AAC(6')-Ian, and ESBL, TLA-3, from a Serratia marcescens clinical isolateWanchun Jin
Department of Bacteriology, Nagoya University Graduate School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya, Aichi 466 8550, Japan
J Antimicrob Chemother 70:1331-7. 2015..The aim of this study was to clarify the molecular mechanisms underlying amikacin resistance in Enterobacteriaceae clinical isolates that do not produce 16S rRNA MTases...
- Pharmacokinetics of continuous-infusion meropenem for the treatment of Serratia marcescens ventriculitis in a pediatric patientJeffrey J Cies
St Christopher s Hospital For Children, Philadelphia, Pennsylvania Drexel University College of Medicine, Philadelphia, Pennsylvania Alfred I duPont Hospital for Children, Wilmington, Delaware
Pharmacotherapy 35:e32-6. 2015..case report, we describe the pharmacokinetics of continuous-infusion meropenem for a 2-year-old girl with Serratia marcescens ventriculitis...
- Protist predation can select for bacteria with lowered susceptibility to infection by lytic phagesAnni Maria Ormälä-Odegrip
Centre of Excellence in Biological Interactions, Department of Biological and Environmental, University of Jyvaskyla, P O Box, 35, 40014, Jyvaskyla, Finland
BMC Evol Biol 15:81. 2015..As a study system we used Serratia marcescens and its lytic bacteriophage, along with two bacteriovorous protists with distinct feeding modes: ..
- Secondary metabolites produced by marine streptomyces as antibiofilm and quorum-sensing inhibitor of uropathogen Proteus mirabilisKhansa Mohammed Younis
School of Biosciences and Biotechnology, Faculty of Science and Technology, University Kebangsaan Malaysia UKM, 43600 UKM Bangi, Selangor, Malaysia
Environ Sci Pollut Res Int 23:4756-67. 2016..screened as anti-quorum-sensing by inhibiting quorum-sensing regulated prodigiosin biosynthesis of Serratia marcescens strain Smj-11 as a reporter strain...
- Y-linked variation for autosomal immune gene regulation has the potential to shape sexually dimorphic immunityIan C Kutch
Department of Biology, University of Central Florida, Biological Sciences Building, 4110 Libra Drive, Orlando, FL 32816, USA
Proc Biol Sci 282:20151301. 2015..We found that Y-line males differed in their immune gene regulation and their ability to defend against Serratia marcescens. Moreover, gene expression and bacterial defence were positively genetically correlated...
- ENZYMOLOGY OF ANTIBIOTIC RESISTANCERichard Armstrong; Fiscal Year: 2009..Plasmid encoded versions of FosA and FosX have been found in multi-drug resistant plasmids Serratia marcescens and P. putida...
- Eric Pearlman; Fiscal Year: 2016..Proposed experiments will also examine TLR responses to Pseudomonas aeruginosa and Serratia marcescens, which cause bacterial keratitis...
- ROBERT M SHANKS; Fiscal Year: 2014..Bacterial keratitis is a costly and global problem that results in vision loss and blindness, and Serratia marcescens is a leading agent of community-acquired Gram-negative bacterial keratitis. S...
- Characterization of Hemolysin A from Proteus mirabilisTodd Weaver; Fiscal Year: 2004..for the secretion of large exoproteins, including the Ca2+-independent cytolysins/hemolyins from Serratia marcescens, Edwardsiella tarda, Yersinia pestis and Proteus mirabilis...
- Novel anti-bacterial therapy for gram negative pneumoniaKanneganti Murthy; Fiscal Year: 2001..strategies that target the N-terminal domain of flagellin reduce mortality in LD9O-100 murine models of Serratia marcescens induced acute pneumonia to less than 10 percent...
- HPMB AS A MODEL FOR HEMOLYSIN SECRETION/ACTIVATIONTIMOTHY UPHOFF; Fiscal Year: 1999..Proteins related to HpmA and B have been identified as virulence factors among other species of Proteus, Serratia marcescens and a variety of other gram-negative bacterial pathogens...
- EVOLUTION AND REGULATION OF MERCURIAL RESISTANCE GENESTAPAN MISRA; Fiscal Year: 1992..The regulatory genes from the broad spectrum mercurial resistance operons of the Serratia marcescens plasmid pDU1358 and Staphylococcus aureus plasmid pI258 will be cloned into a hyperexpression vector (pI258)..
- Evolutionary Genomics of Anti-Malaria Genes in MosquitoBrian P Lazzaro; Fiscal Year: 2010..Evolutionary patterns in mosquito defense genes will be used to identify proteins that coevolve with malaria parasites. This work may suggest genetic targets that could be manipulated to limit malaria transmission. ..
- Gene expression in commensal tsetse symbiontsBrian Weiss; Fiscal Year: 2007..These 'paratransgenic' flies and their offspring will then be monitored for changes in fitness, stability of recombinant protein expression and trypanosome vectorial capacity. ..
- Campylobacter jejuni proteins induced at 37CStuart Thompson; Fiscal Year: 2007..jejuni proteins that are induced at 37C.Specific Aim 3. Elucidate the roles of specific 37C-induced proteins in human epithelial cell binding and invasion in vitro, and in colonization in a mouse model. ..
- Susceptibility Testing, Treatment Choices, and Outcomes of MDR-GNB InfectionsLisa Maragakis; Fiscal Year: 2009..This research is designed to better understand how providers use information from various microbiology laboratory testing methods to choose treatments and to identify strategies that lead to the best patient outcomes. ..
- Prevention of Healthcare-Associated Drug-Resistant GNRLisa Maragakis; Fiscal Year: 2006..Maragakis with the skills she needs to develop into an independent clinical investigator in epidemiologic research for the prevention of healthcare-associated infections. ..
- Campylobacter jejuni outer membrane protein vaccineStuart Thompson; Fiscal Year: 2009..Specific Aim 3. We will determine whether immunization of mice with conserved, purified recombinant OMPs protects against subsequent experimental C. jejuni infection. ..
- Campylobacter jejuni DNA methylation and gene regulationStuart Thompson; Fiscal Year: 2004..Specific Aim 3. Elucidate the upstream factors and signals controlling Cj1461 and Cj0355 expression to reveal the entire regulatory circuit. ..
- CAMPYLOBACTER FETUS SURFACE LAYER PROTEIN SECRETIONStuart Thompson; Fiscal Year: 2002..coli. They will use deletion and mutational analyses to define the C. fetus SapA C-terminal secretion signal. The ability of the SapA secretion to mediate the transport of normally non-secreted proteins also will be assessed. ..
- COMPOSITIONS AND METHODS FOR INHIBITION OF PATHOGENIC BACTERIAL GROWTHPatent Number: JP2016509002-A; Date:2016-03-24
- COMPOSITIONS AND METHODSPatent Number: JP2016509003-A; Date:2016-03-24
- NETWORK-BASED MICROBIAL COMPOSITIONS AND METHODSPatent Number: JP2016519664-A; Date:2016-07-07
- DETECTION METHODPatent Number: WO2016067047-A1; Date:2016-05-06
- PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBYPatent Number: EP3034607-A1; Date:2016-06-22
- PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBYPatent Number: JP2015062422-A; Date:2015-04-09
- SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOFPatent Number: JP2015537042-A; Date:2015-12-24
- Expression cassettePatent Number: WO2015115610-A; Date:2015-08-06
- Protease screening methods and proteases identified therebyPatent Number: KR1020150033726-A; Date:2015-04-01
- SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOFPatent Number: KR1020150108357-A; Date:2015-09-25
- COMPOSITIONS AND METHODSPatent Number: KR1020150115888-A; Date:2015-10-14
- Protease screening methods and proteases identified therebyPatent Number: KR1020150115968-A; Date:2015-10-14
- SELF-COALESCING OR SELF-AGGREGATING CHIMERIC PROTEINS DRIVED FROM A MEMBRANE TRANSLOCATING SEQUENCEPatent Number: JP2005528107-A; Date:2005-09-22
- Method for generating recombinant DNA library usingunidirectional single-stranded DNA fragmentsPatent Number: KR1020010041549-A; Date:2001-07-11
- Method for generating recombinant DNA library using unidirectional single-stranded DNA fragmentsPatent Number: JP2004513633-A; Date:2004-05-13
- No title suppliedPatent Number: WO2006035062-A1; Date:2006-04-06
- METHODS FOR ENHANCING THE DEGRADATION OF CELLULOSIC MATERIAL WITH CHITIN BINDING PROTEINSPatent Number: WO2012159009-A1; Date:2012-11-22
- Protease screening methods and proteases identified therebyPatent Number: EP2402437-A2; Date:2012-01-04
- Gene coding for esterase and novel microorganism containing said genePatent Number: KR1019920022361-A; Date:1992-11-25
- Higher molecular weight entities and uses thereforPatent Number: KR1020047019541-A; Date:2004-11-30
- ENHANCED MULTIPLEX FISHPatent Number: KR1020130003002-A; Date:2013-01-08
- A method for controlling degradation of proteins by tetracyclines antibioticsPatent Number: WO2007032555-A; Date:2007-03-22
- Nucleic acid molecules for the detection of bacteria and phylogenetic units of bacteriaPatent Number: JP2003534770-A; Date:2003-11-25
- A method for controlling both transcription of the gene of a protein of interest and degradation thereof by antibioticsPatent Number: WO2008114856-A; Date:2008-09-25
- METHOD FOR THE DETECTION AND/OR IDENTIFICATION A MICROORGANISMPatent Number: JP2009502142-A; Date:2009-01-29
- GENE AND USE THEREOFPatent Number: JP1988102684-A; Date:1988-05-07
- GENE CAPABLE OF CODING ESTERASE AND NEW MICROORGANISM CONTAINING THE SAME GENEPatent Number: JP1993344891-A; Date:1993-12-27
- Modified Microbial Nucleic AcidPatent Number: JP2009538603-A; Date:2009-11-12
- Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteriaPatent Number: WO0123606-A2; Date:2001-04-05
- Highly conserved genes and their use to generate probes and primers for detection of microorganismsPatent Number: WO0123604-A2; Date:2001-04-05
- PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBYPatent Number: JP2009542218-A; Date:2009-12-03
- Chimeric proteins for detection and quantitation of dna mutations, dna sequence variations, dna damage and dna mismatchesPatent Number: WO0173079-A2; Date:2001-10-04
- NUCLEIC ACID SEQUENCES AND COMBINATION THEREOF FOR SENSITIVE AMPLIFICATION AND DETECTION OF BACTERIAL AND FUNGAL SEPSIS PATHOGENSPatent Number: JP2010532665-A; Date:2010-10-14
- Transgenic pathogen resistant organismPatent Number: EP0616035-A2; Date:1994-09-21
- Plants with increased tolerance and/or resistance to environmental stress and increased biomass productionPatent Number: WO2008142034-A2; Date:2008-11-27
- Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae familyPatent Number: EP2036979-A1; Date:2009-03-18
- Plants with increased yieldPatent Number: WO2009037279-A1; Date:2009-03-26
- Plants with increased yieldPatent Number: WO2009037329-A2; Date:2009-03-26
- Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae familyPatent Number: EP2055785-A1; Date:2009-05-06
- Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae familyPatent Number: EP2060636-A1; Date:2009-05-20
- Process for the production of luteinPatent Number: EP2096177-A2; Date:2009-09-02
- Novel glycerol dehydrogenase and utilization thereofPatent Number: JP2003061668-A; Date:2003-03-04
- Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae familyPatent Number: EP2133420-A1; Date:2009-12-16
- Method for manufacturing organic chemical compounds using improved strains of the enterobacteriaceae familyPatent Number: EP2163613-A2; Date:2010-03-17
- Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance biotic stressPatent Number: WO2010037714-A1; Date:2010-04-08
- Process for the control of production of fine chemicalsPatent Number: EP2199304-A1; Date:2010-06-23
- Novel gtp cyclohydrolase type ibPatent Number: EP2201107-A2; Date:2010-06-30
- Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae familyPatent Number: EP2267145-A1; Date:2010-12-29
- Method for the detection and/or identification of a microorganismPatent Number: EP2363497-A2; Date:2011-09-07
- A METHOD OF INTERSTRAIN DIFFERENTIATION OF BACTERIAPatent Number: WO9951771-A1; Date:1999-10-14
- HIGHLY CONSERVED GENES AND THEIR USE TO GENERATE SPECIES-SPECIFIC, GENUS-SPECIFIC, FAMILY-SPECIFIC, GROUP-SPECIFIC AND UNIVERSAL NUCLEIC ACID PROBES AND AMPLIFICATION PRIMERS TO RAPIDLY DETECT AND IDENTIFY ALGAL, ARCHAEAL, BACTERIAL, FUNGAL AND PARASITICAL MICROOR-GANISMS FROM CLINICAL SPECIMENS FOR DIAGNOSISPatent Number: JP2003511015-A; Date:2003-03-25
- Nucleic Acid Beacons for Fluorescent in-situ Hybridisation and Chip TechnologyPatent Number: JP2010505429-A; Date:2010-02-25
- A method for controlling degradation of proteins by tetracyclines antibioticsPatent Number: JP2011206055-A; Date:2011-10-20
- Process and Method for Monitoring Gastrointestinal MicrobiotaPatent Number: JP2011527177-A; Date:2011-10-27
- PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBYPatent Number: JP2010075209-A; Date:2010-04-08
- PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBYPatent Number: JP2012034701-A; Date:2012-02-23
- Enhanced Multiplex FISHPatent Number: JP2013520980-A; Date:2013-06-10
- Methods for detecting and differentiating bacteriaPatent Number: WO2004029299-A2; Date:2004-04-08
- PROCESS AND METHOD FOR MONITORING GASTROINTESTINAL MICROBIOTAPatent Number: EP2271771-A2; Date:2011-01-12
- METHOD FOR PRODUCING NUCLEASES OF A GRAM NEGATIVE BACTERIUM WHILE USING A GRAM POSITIVE EXPRESSION HOSTPatent Number: WO2011015327-A1; Date:2011-02-10
- METHOD FOR DETECTING THE PRESENCE OF BACTERIAL STRAINS RESISTANT TO ANTIBIOTICS IN A BIOLOGICAL SAMPLEPatent Number: WO2012032158-A1; Date:2012-03-15
- Protease screening methods and proteases indentified thererbyPatent Number: WO2008045148-A1; Date:2008-04-17